Found on
Group by:
Title Date Type
FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma
FDA News Release (11/14/19)
FDA on Thursday granted accelerated approval to zanubrutinib (Brukinsa—BeiGene USA) capsules for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy. "Mantle cell lymphoma usually responds well to initial treatment, but eventually returns or…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Phase III efficacy trial of modified vaccinia Ankara as a vaccine against smallpox
New England Journal of Medicine (11/14/19) Vol. 381, No. 20, P. 1897 Pittman, Phillip R.; Hahn, Matthew; Lee, HeeChoon S.; et al.
Adverse events associated with traditional smallpox vaccines—which are based on replicating vaccinia viruses—underscore the need for safer alternatives, given that many countries are stockpiling vaccine in case of a reemergence. One prospect under development is modified vaccinia Ankara…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
The deadliest form of plague has infected two people in China, and information is scarce
Washington Post (11/13/19) Brice-Saddler, Michael
Local health officials in China have confirmed two cases of pneumonic plague. Authorities say two people from China’s Inner Mongolia region received "proper treatment" and that "relevant disease prevention and control measures have been taken." The patients were reportedly treated at the…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Drugs that worsen HF common in hospitalized HF
Medscape (11/11/19) Yasgur, Batya Swift
A new study published online in JACC Heart Failure reveals that several commonly prescribed medications that worsen heart failure (HF) are often continued or even initiated after an HF hospitalization. Researchers examined the use of major drugs that aggravate HF both at hospital admission and at…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Diabetics make insulin for first time with stem cell-derived therapy
San Diego Union-Tribune (11/10/19) Fikes, Bradley J.
At the recent Cell and Gene Meeting on the Mesa in Carlsbad, CA, companies discussed advances in stem cell therapies. ViaCyte described two versions of an experimental diabetes treatment that features insulin-producing cells grown from embryonic stem cells. The cells are stored in a device that is…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Diplomat Pharmacy's stock plunges to record low after 'going concern' warning
MarketWatch (11/13/19) Kilgore, Tomi
Shares of Diplomat Pharmacy Inc. fell 50% after the specialty pharmacy company disclosed a "going concern warning" as it reported wider-than-expected losses for a third consecutive quarter. In its third quarter earnings release, Diplomat warned that it may not be able to meet the net leverage and…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Rite Aid Foundation donates to wildfire relief
Chain Drug Review (11/11/19)
To support wildfire relief efforts in California, the Rite Aid Foundation says it will distribute $75,000 to the American Red Cross Los Angeles Region and American Red Cross Northern California Coastal Region. Tracy Henderson, director of the Rite Aid Foundation and charitable giving initiatives,…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Student pharmacists help out to stop hepatitis A outbreak in Washington state
Yakima Herald-Republic (11/09/19) Hoang, Mai
Washington State University student pharmacists are helping to respond to an outbreak of hepatitis A in Yakima, WA. The Yakima Health District recently said that five acute cases of the infectious disease had been reported among individuals experiencing homelessness and illicit drug users; there…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Naloxone program taps the pharmacy's appeal as point-of-care destination
Medical Marketing & Media (11/04/19) Dobrow, Larry
The bulk of point-of-care marketing currently targets medical practices, but pharmacies remain a priority for many marketers. A new program developed by Rx Edge Media Network, CVS Health, and Emergent BioSolutions attempts to leverage that rising demand and appetite. The program was unveiled across…
Nov 14, 2019 Publication Pharmacy Today Daily Edition
Senators press FDA tobacco chief on status of vaping ban
The Hill (11/13/19) Weixel, Nathaniel
Members of the Senate Health Committee on Wednesday pressed Mitch Zeller, the head of FDA's Center for Tobacco Products, for information about the administration's efforts to remove e-cigarette flavors from the market. Zeller said the agency is working on an e-cigarette policy, but declined to give…
Nov 14, 2019 Publication Pharmacy Today Daily Edition